Mark M. Painter

4.6k citations
31 papers · 3.0k · 5 hit papers · h-index 17

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

    • SARS-CoV-2 and COVID-19 Research 12
    • COVID-19 Clinical Research Studies 6
    • HIV/AIDS drug development and treatment 4
    • SARS-CoV-2 detection and testing 3
    • HIV Research and Treatment 9

Mark M. Painter

28 papers receiving 2.9k citations

Mark M. Painter's Hit Papers

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) 2023 · 195 citations
1950+1+3Years since publication200400600

Peers

Mark M. Painter
Comparison fields: 5 of 98
  • Infectious Diseases 2.0k
  • Immunology 882
  • Virology 130
  • Modeling and Simulation 119
  • Neurology 333
Replace Alison Tarke with:
Alison Tarke United States
Ricardo da Silva Antunes United States
Wenzhao Meng United States
Michael K. Klebert United States
Nicholas M. Provine United Kingdom
Kendall A. Lundgreen United States
Catherine Nakao United States
Sally A. Shin United States
Kanika Vanshylla Germany
Charlotte Viant United States
Mark M. Painter relative to Alison Tarke United States Alison Tarke's profile →
Citations per field
00.5×1.6×
Alison Tarke · 1×
Citations per year

Countries citing papers authored by Mark M. Painter

Since Specialization
Citations

This map shows the geographic impact of Mark M. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Painter more than expected).

Fields of papers citing papers by Mark M. Painter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Painter. The network helps show where Mark M. Painter may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark M. Painter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark M. Painter Line = papers co-authored together Mark M. Painter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Hit paper breakdown →
2021668
2
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Hit paper breakdown →
2021494
3
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Hit paper breakdown →
2021409
4
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
Hit paper breakdown →
2021385
5
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Hit paper breakdown →
2023195
6 2022176
7 2022157
8 2022133
9 202369
10 202451
11 201849
12 201837
13 202229
14 202027
15 202520
16 201718
17 202217
18 202217
19 202016
20 20068

About Mark M. Painter

Mark M. Painter is a scholar working on Infectious Diseases, Virology, Immunology, Public Health, Environmental and Occupational Health and Neurology, having authored 31 papers that have together received 3.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), HIV Research and Treatment (9 papers), COVID-19 Clinical Research Studies (6 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers), HIV/AIDS drug development and treatment (4 papers), SARS-CoV-2 detection and testing (3 papers) and Mosquito-borne diseases and control (3 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Immunology (882 citations), Virology (130 citations), Modeling and Simulation (119 citations) and Neurology (333 citations). Mark M. Painter has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Kathleen L. Collins, E. John Wherry, Valeri H. Terry, Rishi R. Goel, Yinghui Huang, Patrick Yan, Omar Khan, Alexander Chan Chi Huang, Tara C. Mitchell and Giorgos Constantine Karakousis. Their work appears in journals such as Nature Immunology, Cell Reports, Cell, Journal of Virology and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact